| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.6 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.14 | 0.6 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |